相关实验视频

Updated: Jul 26, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

在转移性黑色素瘤中,部位的重要性

Haley P Wilson¹, Andrew E Aplin²

¹Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Trends in cancer

|June 18, 2023

概括

这项研究调查了转移性黑色素瘤 (MM) 如何对向治疗和免疫检查点阻塞 (ICB) 产生耐药性. 研究人员分析了尸检瘤,以了解黑色素瘤患者的抵抗机制和器官特异性基因变化.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫治疗是一种免疫疗法.

背景情况:

转移和对基因激活蛋白激酶 (MAPK) 抑制和免疫检查点阻塞 (ICB) 的抵抗在黑色素瘤治疗中构成重大挑战.
了解治疗耐药性背后的机制对于改善患者的治疗结果至关重要.

研究的目的:

剖析转移性黑色素瘤 (MM) 治疗耐药性的基因组和转录组特征.
为了识别与黑色素瘤转移相关的器官特异性基因特征.
探索MM与不同器官部位之间的交叉声.

主要方法:

利用转移性黑色素瘤 (MM) 瘤的快速尸检队列.
进行基因组和转录组分析以确定分子变化.
与特定器官转移部位相关的分子发现.

主要成果:

确定了与抵抗MAPK抑制和ICB相关的独特的基因组和转录组资料.
在转移性黑色素瘤中发现了特定器官的基因表达特征.
提供了有关黑色素瘤和宿主器官之间的分子相互作用的见解.

结论:

黑色素瘤的耐疗性是复杂的,受到基因组和转录组变化的影响.
特定器官的微环境在塑造黑色素瘤转移和抵抗方面发挥着作用.
对这些机制的进一步研究可能会导致黑色素瘤的新型治疗策略.

关键词:

的交叉电阻.交叉语音交叉语音交叉语音交叉语音黑色素瘤是一种黑色素瘤.转移转移转移转移微观环境是一个微观环境.治疗耐药性治疗耐药性

更多相关视频

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...